Table 1.
Stilbene Compounds | Cell Models | Target/Mechanism | Outcome | Reference |
---|---|---|---|---|
Resveratrol | ||||
RSV | U-87MG | hTERT mRNA↓ | cell growth↓, cell death↑ | [140] |
RSV | HT-29, WiDr | Telomerase activity↓ | cell proliferation↓ | [141] |
RSV | MCF-7 | Telomerase activity↓ hTERT expression↓ |
S phase arrest↑ apoptosis↑ |
[142] |
RSV | Ovaria cancer cells | hTERT expression↓ Slug↓, pScr and HIF-1α↓ |
EMT↓ invasion↓ |
[143] |
Resveratrol Derivatives | ||||
RSV derivative (E)-4-(4-methoxystyryl) aniline | Colon cancer cells | hTERT expression↓ cMyc expression↓ |
cytotoxicity↑ | [144] |
RSV derivative 3,3’,4,4’,5,5’-Hexahydroxy-trans-Stilbene (M8) | Human peritoneal mesothelial cells | mitochondrial reactive oxygen species↑ | senescence↑, cell cycle arrest↑ |
[145] |
RSV sulfate metabolites | HT29, MCF-7 | hTERT mRNA↓, cMyc ↓ | cell death↑ | [146] |
Resveratrol Combined Therapy | ||||
RSV + XRT | Prostate cancer cells | p21CIP1/WAF1, p27Kip1, p53↑ Fas, TRAIL1↑, p-H2AX↑ |
senescence↑ apoptosis↑ |
[147] |
RSV + IR | Lung cancer cells | ROS↑, DDR↑ | senescence | [148] |
RSV + quercetin | Rat glimoma cells | caspase 3/7 activation↑ | senescence | [149] |
RSV + 5-FU | Colon cancer cells | Telomerase activity↓ Stat3 and Akt↓ |
apoptosis | [150,151] |
RSV + TMZ | Glioblastoma cells | Mitotic catastrophe p-ATM, p-Chk2↑ |
senescence↑ autophagy↑ |
[152] |
Pterostilbene | ||||
PT | Lung cancer cells | Molecular docking to hTERT | cell death | [153] |
PT | Lung cancer cells | ATM-CHK-p53 | senescence↑ | [154] |
PT | Breast cancer cells | cMyc expression↓ hTERT expression↓ |
apoptosis cell cycle arrest |
[155] |
PT | Lung cancer cells | hTERT activity↓, hTERT expression↓, DDR↑, p53-dependent | S phase arrest↑ senescence↑ |
[134] |
PIC | Hepatic stellate cell | p16INK4a↑, p53↑ Bcl-xl↓, SMAD↓ |
Inflammation↓ hepatocarcinogenesis↓ |
[156] |